Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Deficit

v3.20.2
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
Total
Series A Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2018   0 58,270,934      
Beginning balance at Dec. 31, 2018 $ (15,422,443) $ 0 $ 58,271 $ 126,076,782 $ (141,557,496) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares)     7,183,488      
Issuance of common stock 5,928,235   $ 7,184 5,921,051    
Stock options and warrants exercised (in shares)     517,224      
Stock options and warrants exercised 1,973   $ 517 1,456    
Deemed dividend (in shares)     116,496      
Deemed dividend 0   $ 116 86,091 (86,207)  
Stock-based compensation 1,211,629     1,211,629    
Effect of reclassification of warrants 857,072     857,072    
Common stock issued for payment of Series B Preferred Stock dividend 6,709,961     6,709,961    
Common stock issued for payment of series B preferred stock dividend (in shares)     101,471      
Common stock issued for preferred stock dividends 166,771   $ 102 166,669    
Net loss (37,817,959)       (37,817,959)  
Ending balance (in shares) at Sep. 30, 2019   0 66,189,613      
Ending balance at Sep. 30, 2019 (38,364,761) $ 0 $ 66,190 141,030,711 (179,461,662) 0
Beginning balance (in shares) at Jun. 30, 2019   0 66,081,812      
Beginning balance at Jun. 30, 2019 (27,374,629) $ 0 $ 66,082 140,527,364 (167,968,075) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised (in shares)     6,330      
Stock options and warrants exercised 1,973   $ 6 1,967    
Stock-based compensation 334,711     334,711    
Common stock issued for payment of series B preferred stock dividend (in shares)     101,471      
Common stock issued for preferred stock dividends 166,771   $ 102 166,669    
Net loss (11,493,587)       (11,493,587)  
Ending balance (in shares) at Sep. 30, 2019   0 66,189,613      
Ending balance at Sep. 30, 2019 (38,364,761) $ 0 $ 66,190 141,030,711 (179,461,662) 0
Beginning balance (in shares) at Dec. 31, 2019   0 67,105,000      
Beginning balance at Dec. 31, 2019 (34,913,110) $ 0 $ 67,105 143,826,315 (178,806,530) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares)     32,158,980      
Stock options and warrants exercised, and vesting of restricted shares 77,811,904   $ 32,159 77,779,745    
Stock-based compensation $ 2,767,734     2,767,734    
Common stock issued for payment of series B preferred stock dividend (in shares) 900,000   920,901      
Common stock issued for preferred stock dividends $ 1,491,860   $ 922 1,490,938    
Conversion of convertible note (in shares)     14,449,846      
Conversion of Convertible Note 148,977,683   $ 14,450 148,963,233    
Common stock issued for interest payment on convertible note (in shares)     328,418      
Common stock issued for interest on Convertible Note 1,283,695   $ 328 1,283,367    
Net loss (210,705,940)          
Other comprehensive income 1,100,000         1,100,000
Ending balance (in shares) at Sep. 30, 2020   0 114,963,145      
Ending balance at Sep. 30, 2020 (12,186,174) $ 0 $ 114,964 376,111,332 (389,512,470) 1,100,000
Beginning balance (in shares) at Jun. 30, 2020   0 89,330,123      
Beginning balance at Jun. 30, 2020 (70,476,795) $ 0 $ 89,330 233,715,623 (305,381,748) 1,100,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options and warrants exercised, and vesting of restricted shares (in shares)     19,247,746      
Stock options and warrants exercised, and vesting of restricted shares 30,653,505   $ 19,248 30,634,257    
Stock-based compensation $ 738,516     738,516    
Common stock issued for payment of series B preferred stock dividend (in shares) 300,000   303,617      
Common stock issued for preferred stock dividends $ 491,860   $ 304 491,556    
Conversion of convertible note (in shares)     6,065,576      
Conversion of Convertible Note 110,242,664   $ 6,066 110,236,598    
Common stock issued for interest payment on convertible note (in shares)     16,083      
Common stock issued for interest on Convertible Note 294,798   $ 16 294,782    
Net loss (84,130,722)       (84,130,722)  
Other comprehensive income 0          
Ending balance (in shares) at Sep. 30, 2020   0 114,963,145      
Ending balance at Sep. 30, 2020 $ (12,186,174) $ 0 $ 114,964 $ 376,111,332 $ (389,512,470) $ 1,100,000